First Eagle Investment Management LLC grew its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 0.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,918,979 shares of the company’s stock after acquiring an additional 29,876 shares during the period. First Eagle Investment Management LLC’s holdings in Colgate-Palmolive were worth $625,758,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also made changes to their positions in CL. Maseco LLP purchased a new position in shares of Colgate-Palmolive in the fourth quarter valued at about $27,000. Copia Wealth Management purchased a new position in shares of Colgate-Palmolive in the third quarter valued at about $29,000. Cloud Capital Management LLC purchased a new position in shares of Colgate-Palmolive in the third quarter valued at about $30,000. Global Wealth Strategies & Associates lifted its position in shares of Colgate-Palmolive by 300.0% in the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock valued at $32,000 after acquiring an additional 300 shares in the last quarter. Finally, Grove Bank & Trust lifted its position in shares of Colgate-Palmolive by 182.6% in the fourth quarter. Grove Bank & Trust now owns 407 shares of the company’s stock valued at $32,000 after acquiring an additional 263 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Trading Down 1.0%
Shares of CL stock opened at $86.68 on Tuesday. The company has a market cap of $69.54 billion, a PE ratio of 33.73, a price-to-earnings-growth ratio of 4.54 and a beta of 0.31. The stock’s 50 day simple moving average is $86.98 and its two-hundred day simple moving average is $84.46. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67.
Colgate-Palmolive Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a dividend of $0.53 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s payout ratio is 82.49%.
Analysts Set New Price Targets
A number of research firms recently commented on CL. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 8th. Jefferies Financial Group boosted their target price on Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Barclays boosted their target price on Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 5th. Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a research report on Monday, May 4th. Finally, TD Cowen reiterated a “hold” rating and issued a $85.00 target price on shares of Colgate-Palmolive in a research report on Tuesday, March 31st. Twelve research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $95.88.
View Our Latest Research Report on Colgate-Palmolive
Insider Transactions at Colgate-Palmolive
In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at approximately $1,018,691.15. This trade represents a 59.02% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.43% of the company’s stock.
About Colgate-Palmolive
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
